Candace Black‐Schaefer

Structure–activity relationships of novel potent MurF inhibitors

Yu Gu, Alan S. Florjancic, Richard F. Clark et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 47 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays

Linda E. Chovan, Candace Black‐Schaefer, Peter J. Dandliker et al. · Rapid Communications in Mass Spectrometry · 2004 · 38 citations

Pharmacy, Biochemistry, Pharmacology +16

Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit

Bradley J. Backes, Kenton L. Longenecker, Gregory L. Hamilton et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 37 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Structure‐based Optimization of MurF Inhibitors

G.F. Stamper, Kenton L. Longenecker, Elizabeth H. Fry et al. · Chemical Biology & Drug Design · 2005 · 36 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Novel AntibacterialClass

Peter J. Dandliker, Steve D. Pratt, Angela M. Nilius et al. · Antimicrobial Agents and Chemotherapy · 2003 · 35 citations · Full text

Life Sciences, Microbiology, Pharmacology +17